Compare Illumina, Inc. (ILMN) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Consumer Staples Select Sector SPDR Fund — how do they compare? Illumina, Inc. trades at $191.76 (market cap $29.12B), while Consumer Staples Select Sector SPDR Fund trades at $84.46. The key difference: Illumina, Inc. is trading nearer its 52-week high, Consumer Staples Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| ILMN | XLP | |
|---|---|---|
Market Cap | $29.12B | — |
Sector | Health | — |
52-Week High | $205.10 | $90.00 |
52-Week Low | $91.00 | $75.61 |
Enterprise Value | $30.48B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $191.79, up 2.04% today, with a neutral technical signal and strong fundamental recovery. The stock shows bullish moving averages but faces resistance near $194. Recent earnings beats and a return to profitability in 2025, with $850M net income, highlight operational turnaround. Revenue remains stable around $4.3B, supported by robust gross margins of 66.38%.
Outlook is positive with analyst consensus Buy rating and $201.58 price target, though high P/E of 35.98 poses valuation risk. Key opportunities include sequencing demand and AI partnerships, while risks involve debt levels and competitive pressures. Institutional activity is mixed, with some funds increasing stakes amid earnings momentum.
XLP, the Consumer Staples Select Sector SPDR ETF, trades at $84.585, down 0.43% today. Technical indicators show a neutral overall signal with bullish moving averages, while oscillators remain neutral. The ETF's 2.6% dividend yield provides income appeal, with a dividend scheduled for payment on June 24, 2026. Recent news highlights consumer staples as a defensive play amid market rotation, with Coca-Cola's strong Q2 2026 earnings underscoring sector resilience (ETF Trends, July 29, 2026).
Outlook remains positive given 100% analyst buy ratings and defensive positioning during economic uncertainty. Key risks include sector concentration and sensitivity to consumer spending shifts. The ETF's stability and income generation support a favorable risk-reward profile for conservative investors seeking exposure to essential consumer goods.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
